Treace Medical Concepts Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Treace Medical Concepts, Inc. (TMCI) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-55.74-49.53-42.82-20.55-3.67
Depreciation & Amortization8.424.852.250.881.21
Stock Based Compensation30.6017.358.113.410.92
Change in Working Capital-25.43-9.74-5.81-0.98-4.17
Change in Accounts Receivable-5.69-9.30-11.04-4.23-4.29
Change in Inventory-10.01-9.85-8.77-2.74-2.26
Change in Accounts Payable-1.313.174.611.791.33
Change in Other Working Capital-8.426.242.794.191.04
Other Operating Activities4.992.6715.893.510.64
Net Cash from Operating Activities-37.17-34.58-30.65-17.20-4.49
Investing Activities
Capital Expenditures-11.59-11.4614.842.71-1.07
Acquisitions0.00-20.000.000.000.00
Purchases of Investments-71.58-49.84-63.410.000.00
Sales/Maturities of Investments118.55120.02-61.680.000.00
Net Cash from Investing Activities35.38-81.30-76.52-2.71-1.07
Financing Activities
Debt Repayment0.000.00-1.16-1.86-20.00
Common Stock Issued0.43116.902.19107.610.36
Common Stock Repurchased0.00-0.010.000.000.00
Other Financing Activities-0.27-7.5019.61-10.60-0.18
Net Cash from Financing Activities0.16109.3820.81107.6511.50
Summary
Net Change in Cash-1.63-6.49-86.3687.755.94
Cash at Beginning of Period12.9819.47105.8318.080.00
Cash at End of Period11.3512.9819.47105.830.00
Free Cash Flow-48.76-46.03-45.49-19.91-5.56
Supplemental Disclosures
Interest Paid4.965.174.403.901.15